Evidence map›Paper›PMID 42294306›Full record

ArticleFrontiers in oncology2026

TNM staging of esophageal cancer using fine-tuned pathology foundation models and multiple instance learning.

Junxiang Cao, Jiacheng Wang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Junxiang CaoSchool of Computer, Jiangsu University of Science and Technology, Zhenjiang, China.
Jiacheng WangManteia Technology, Co., Ltd., Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal cancer is a common and aggressive malignancy worldwide. Accurate TNM staging is essential for clinical decision-making and prognosis. While whole slide images (WSIs) offer rich histopathological details for automated staging, their sheer size and complexity make manual analysis subjective and time-consuming. Consequently, advanced deep learning models are critically needed to improve the accuracy and efficiency of WSI-based TNM staging. Methods: We propose a novel deep learning approach that integrates a fine-tuned pathology foundation model within a Multiple Instance Learning (MIL) framework for automated TNM staging from WSIs. To boost predictive accuracy, our model is enhanced with a feature attention mechanism to pinpoint critical tumor areas and an adaptive layer for effective multi-scale feature fusion. Furthermore, we developed a class-weighted cross-entropy loss function to address pronounced TNM stage imbalance, targeting composite pathological stage classification as a single multi-class prediction task rather than separate T, N, and M components. Performance was rigorously evaluated using three-fold cross-validation and benchmarked against state-of-the-art methods. Results: Our model achieved outstanding performance on the TCGA-ESCA dataset, outperforming existing methods in accuracy, macro F1-score, and AUC. These results confirm the model's effectiveness. Visualization analysis further showed that the model accurately localizes tumor regions and their boundaries, increasing the interpretability and reliability of its predictions. Conclusion: Our study validates the potential of a WSI-based deep learning approach for accurate prediction of esophageal cancer's TNM stage. This tool has the potential to augment pathological diagnosis, refine patient risk assessment, and ultimately guide better treatment strategies.

Indexed as

esophageal cancerfoundation modelmultiple instance learningTNM stagingwhole slide imaging

Identifiers

PMID42294306
PMCPMC13259655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.